Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
166.9 USD | -0.51% | +1.41% | +7.75% |
05:07pm | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.